Kittinan Komolpis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kittinan Komolpis has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Songchan Puthong
5 shared publications- Tanapat Palaga
Department of Microbiology, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand
4 shared publications Umaporn Pimpitak
3 shared publicationsMohini M. Sain
2 shared publicationsPatamalai Boonserm
Program in Biotechnology, Faculty of Science, Chulalongkorn University, Bangkok, Thailand
2 shared publications- Sarintip Sooksai
The Institute of Biotechnology and Genetic Engineering, Chulalongkorn University, Bangkok 10330, Thailand
2 shared publications
Latest Publications
- Open Access
- 25 August 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-9
Investigation of major amino acid residues of anti-norfloxacin monoclonal antibodies responsible for binding with fluoroquinolones
It is important to understand the amino acid residues that govern the properties of the binding between antibodies and ligands. We studied the binding of two anti-norfloxacins, anti-nor 132 and anti-nor 155, and the fluoroquinolones norfloxacin, enrofloxacin, ciprofloxacin, and ofloxacin. Binding cross-reactivities tested by an indirect competitive enzyme-linked immunosorbent assay indicated that anti-nor 132 (22–100%) had a broader range of cross-reactivity than anti-nor 155 (62–100%). These cross-reactivities correlated with variations in the numbers of interacting amino acid residues and their positions. Molecular docking was employed to investigate the molecular interactions between the fluoroquinolones and the monoclonal antibodies. Homology models of the heavy chain and light chain variable regions of each mAb 3D structure were docked with the fluoroquinolones targeting the crucial part of the complementarity-determining regions. The fluoroquinolone binding site of anti-nor 155 was a region of the HCDR3 and LCDR3 loops in which hydrogen bonds were formed with TYR (H:35), ASN (H:101), LYS (H:106), ASN (L:92), and ASN (L:93). These regions were further away in anti-nor 132 and could not contact the fluoroquinolones. Another binding region consisting of HIS (L:38) and ASP (H:100) was found for norfloxacin, enrofloxacin, and ciprofloxacin, whereas only ASP (H:100) was found for ofloxacin.
- 25 August 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-9
Open AccessInvestigation of major amino acid residues of anti-norfloxacin monoclonal antibodies responsible for binding with fluoroquinolones
It is important to understand the amino acid residues that govern the properties of the binding between antibodies and ligands. We studied the binding of two anti-norfloxacins, anti-nor 132 and anti-nor 155, and the fluoroquinolones norfloxacin, enrofloxacin, ciprofloxacin, and ofloxacin. Binding cross-reactivities tested by an indirect competitive enzyme-linked immunosorbent assay indicated that anti-nor 132 (22–100%) had a broader range of cross-reactivity than anti-nor 155 (62–100%). These cross-reactivities correlated with variations in the numbers of interacting amino acid residues and their positions. Molecular docking was employed to investigate the molecular interactions between the fluoroquinolones and the monoclonal antibodies. Homology models of the heavy chain and light chain variable regions of each mAb 3D structure were docked with the fluoroquinolones targeting the crucial part of the complementarity-determining regions. The fluoroquinolone binding site of anti-nor 155 was a region of the HCDR3 and LCDR3 loops in which hydrogen bonds were formed with TYR (H:35), ASN (H:101), LYS (H:106), ASN (L:92), and ASN (L:93). These regions were further away in anti-nor 132 and could not contact the fluoroquinolones. Another binding region consisting of HIS (L:38) and ASP (H:100) was found for norfloxacin, enrofloxacin, and ciprofloxacin, whereas only ASP (H:100) was found for ofloxacin.
- 10 August 2020
- Published by Wiley in International Journal of Dairy Technology
- Vol. 73 (4) , 695-705
Development and validation of a lateral flow immunoassay for the detection of aflatoxin M1 in raw and commercialised milks
Aflatoxin M1 (AFM1), a group I carcinogen, can be found in the milk of animals fed with aflatoxin‐B1‐contaminated feedstuff. In this study, we developed and validated a lateral flow immunoassay (LFIA) with the cut‐off value of 0.5 µg/L for AFM1 screening. The validation revealed that the assay yielded high sensitivity, selectivity and efficiency with no false positives. Forty‐one commercial milk samples were tested for AFM1 by the developed LFIA. However, the developed LFIA could not be applied to milk samples flavoured with chocolate and coffee. Otherwise, all samples gave negative test results.
- 10 August 2020
- Published by Wiley in International Journal of Dairy Technology
- Vol. 73 (4) , 695-705
Development and validation of a lateral flow immunoassay for the detection of aflatoxin M1 in raw and commercialised milks
Aflatoxin M1 (AFM1), a group I carcinogen, can be found in the milk of animals fed with aflatoxin‐B1‐contaminated feedstuff. In this study, we developed and validated a lateral flow immunoassay (LFIA) with the cut‐off value of 0.5 µg/L for AFM1 screening. The validation revealed that the assay yielded high sensitivity, selectivity and efficiency with no false positives. Forty‐one commercial milk samples were tested for AFM1 by the developed LFIA. However, the developed LFIA could not be applied to milk samples flavoured with chocolate and coffee. Otherwise, all samples gave negative test results.
- Open Access
- 1 January 2020
- Published by EJournal Publishing in International Journal of Pharma Medicine and Biological Sciences
- Vol. 9 (2) , 81-86
Kinetics of Binding Interaction between Norfloxacin and Monoclonal Antibody Using Surface Plasmon Resonance
- 1 January 2020
- Published by EJournal Publishing in International Journal of Pharma Medicine and Biological Sciences
- Vol. 9 (2) , 81-86
Open AccessKinetics of Binding Interaction between Norfloxacin and Monoclonal Antibody Using Surface Plasmon Resonance
- Open Access
- 1 June 2017
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 15 (1) , 69-76
Construction and sequencing analysis of scFv antibody fragment derived from monoclonal antibody against norfloxacin (Nor155)
- 1 June 2017
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 15 (1) , 69-76
Open AccessConstruction and sequencing analysis of scFv antibody fragment derived from monoclonal antibody against norfloxacin (Nor155)
- 9 November 2016
- Published by Springer Nature in Journal of Nanoparticle Research
- Vol. 18 (11) , 1-11
Effect of capping agents on the cytotoxicity of silver nanoparticles in human normal and cancer skin cell lines
- 9 November 2016
- Published by Springer Nature in Journal of Nanoparticle Research
- Vol. 18 (11) , 1-11
Effect of capping agents on the cytotoxicity of silver nanoparticles in human normal and cancer skin cell lines
- Open Access
- 30 April 2016
- Published by The Journal of Food and Drug Analysis (JFDA), Food and Drug Administration, Taiwan (TFDA) in Journal of Food and Drug Analysis
- Vol. 24 (4) , 780-787
Production of a monoclonal antibody against aflatoxin M1 and its application for detection of aflatoxin M1 in fortified milk
Aflatoxin M1 (AFM1) is a toxic metabolite of the fungal product aflatoxin found in milk. For food safety concern, maximum residual limits of AFM1 in milk and dairy products have been differently enforced in many countries. A suitable detection method is required to screen a large number of product samples for the AFM1 contamination. In this study, monoclonal antibodies (MAbs) against AFM1 were generated using a conventional somatic cell fusion technique. After screening, five MAbs (AFM1-1, AFM1-3, AFM1-9, AFM1-11, and AFM1-17) were obtained that showed cross-reactivity with aflatoxin B1 (AFB1) and aflatoxin G1 (AFG1) but with no other tested compounds. An indirect competitive enzyme-linked immunosorbent assay (ELISA) using a partially purified MAb and antigen-coated plates yielded the best sensitivity with the 50% inhibition concentration (IC50) and the limit of detection (LOD) values of 0.13 ng/mL and 0.04 ng/mL, respectively. This indirect competitive ELISA was used to quantify the amount of fortified AFM1 in raw milk. The precision and accuracy in terms of % coefficient of variation (CV) and % recovery of the detection was investigated for both intra- (n = 6) and inter- (n = 12) variation assays. The % CV was found in the range of 3.50-15.8% and 1.32-7.98%, respectively, while the % recovery was in the range of 92-104% and 100-103%, respectively. In addition, the indirect ELISA was also used to detect AFM1 fortified in processed milk samples. The % CV and % recovery values were in the ranges of 0.1-33.0% and 91-109%, respectively. Comparison analysis between the indirect ELISA and high performance liquid chromatography was also performed and showed a good correlation with the R2 of 0.992 for the concentration of 0.2-5.0 ng/mL. These results indicated that the developed MAb and ELISA could be used for detection of AFM1 in milk samples.
- 30 April 2016
- Published by The Journal of Food and Drug Analysis (JFDA), Food and Drug Administration, Taiwan (TFDA) in Journal of Food and Drug Analysis
- Vol. 24 (4) , 780-787
Open AccessProduction of a monoclonal antibody against aflatoxin M1 and its application for detection of aflatoxin M1 in fortified milk
Aflatoxin M1 (AFM1) is a toxic metabolite of the fungal product aflatoxin found in milk. For food safety concern, maximum residual limits of AFM1 in milk and dairy products have been differently enforced in many countries. A suitable detection method is required to screen a large number of product samples for the AFM1 contamination. In this study, monoclonal antibodies (MAbs) against AFM1 were generated using a conventional somatic cell fusion technique. After screening, five MAbs (AFM1-1, AFM1-3, AFM1-9, AFM1-11, and AFM1-17) were obtained that showed cross-reactivity with aflatoxin B1 (AFB1) and aflatoxin G1 (AFG1) but with no other tested compounds. An indirect competitive enzyme-linked immunosorbent assay (ELISA) using a partially purified MAb and antigen-coated plates yielded the best sensitivity with the 50% inhibition concentration (IC50) and the limit of detection (LOD) values of 0.13 ng/mL and 0.04 ng/mL, respectively. This indirect competitive ELISA was used to quantify the amount of fortified AFM1 in raw milk. The precision and accuracy in terms of % coefficient of variation (CV) and % recovery of the detection was investigated for both intra- (n = 6) and inter- (n = 12) variation assays. The % CV was found in the range of 3.50-15.8% and 1.32-7.98%, respectively, while the % recovery was in the range of 92-104% and 100-103%, respectively. In addition, the indirect ELISA was also used to detect AFM1 fortified in processed milk samples. The % CV and % recovery values were in the ranges of 0.1-33.0% and 91-109%, respectively. Comparison analysis between the indirect ELISA and high performance liquid chromatography was also performed and showed a good correlation with the R2 of 0.992 for the concentration of 0.2-5.0 ng/mL. These results indicated that the developed MAb and ELISA could be used for detection of AFM1 in milk samples.
- 1 July 2010
- Published by Elsevier in Journal of Industrial and Engineering Chemistry
- Vol. 16 (4) , 567-571
Comparative production of a monoclonal antibody specific for enrofloxacin in a stirred-tank bioreactor
- 1 July 2010
- Published by Elsevier in Journal of Industrial and Engineering Chemistry
- Vol. 16 (4) , 567-571
Comparative production of a monoclonal antibody specific for enrofloxacin in a stirred-tank bioreactor
- 1 October 2009
- Published by Elsevier in Food Chemistry
- Vol. 116 (3) , 785-791
Development of a monoclonal antibody-based enzyme-linked immunosorbent assay for detection of the furaltadone metabolite, AMOZ, in fortified shrimp samples
- 1 October 2009
- Published by Elsevier in Food Chemistry
- Vol. 116 (3) , 785-791
Development of a monoclonal antibody-based enzyme-linked immunosorbent assay for detection of the furaltadone metabolite, AMOZ, in fortified shrimp samples